Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-18 · accession 0001214659-25-004545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-19 | 2025-03-18 | ALZN | Horne William B. | Dir | M - OptEx | $0.06 | +10.0K | 16.7K | +150% | +$600 |
| D | 2025-03-19 | 2025-03-18 | ALZN | Horne William B. | Dir | P - Purchase | $0.97 | +5,000 | 21.7K | +30% | +$4,850 |
| D | 2025-03-19 | 2025-03-18 | ALZN | Horne William B. | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-18 | M | A | 10,000 | $0.06 | 16,666 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-18 | P | A | 5,000 | $0.97 | 21,666 | D | — | — | (F2) The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9703. The range of purchase prices on the transaction date was $0.9693 to $0.9742 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-03-18 | M | D | 10,000 | $0.00 | 0 | D | $0.06 · — to 2026-04-29 | 10,000 Common Stock | (F3) The stock options exercised in this transaction were fully vested and exercisable as of the transaction date. |